Frontiers in Pharmacology | Respiratory Pharmacology

Original Research

Accepted on 10 Jul 2025

Quercetin ameliorates epithelial-mesenchymal transition and inflammation by targeting FSTL1 and modulating the NF-κB Pathway in pulmonary fibrosis

in Respiratory Pharmacology

CuiTing Dong
YueJiao Lan
Mingda Wu
Ruichen Yuan
Kunpeng Yang
Zhen Yang
Yang Chen
JingBin Zhang
BingXue Qi
XiaoDan Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1594757

Original Research

Published on 10 Jul 2025

EPA-lactone derivative, 5,6-diHETE lactone, improves pulmonary arterial hypertension in a monocrotaline-induced model

in Respiratory Pharmacology

Karthik Dhananjayan
Offir Ertracht
Shaul Atar
Alejandro Livoff
Mona Shehadeh
Andrea Szuchman-Sapir

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1621030

356 views

Original Research

Published on 09 Jul 2025

Novel mitophagy inducer TJ0113 alleviates pulmonary inflammation during acute lung injury

in Respiratory Pharmacology

Zhengyuan Liu
Danruo Fang
Kaijun Chen
Lingling Dong
Huaqiong Huang
Zhihua Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1590458

316 views

Case Report

Published on 09 Jul 2025

Case Report: Coadministration of TNF-α blockade as an effective adjunctive strategy in the treatment of ANCA-negative EGPA with refractory peripheral neuropathy

in Respiratory Pharmacology

Dabin Tang
Yubao Jiang
Shuo Yang
Jiaxin Wei
Jingjing Xie
Jianyong Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1555377

219 views

Original Research

Accepted on 04 Jul 2025

Active Surveillance of Adverse Drug Events in Hospitalized Patients with Pulmonary Arterial Hypertension Based on the Global Trigger Tool

in Respiratory Pharmacology

Mengdan Xu
Suzhen He
Guozhi Li
Shunyu Xiong
Guanquan Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1533634

135 views

Original Research

Accepted on 04 Jul 2025

Comparison of Pharmacokinetic Similarity, Immunogenicity, and Safety of Mepolizumab and BAT2606 in Healthy Chinese Men in a Double-blinded, Randomized, Single-dose, Three-arm Parallel-group Phase I Trial

in Respiratory Pharmacology

Cuiyun Li
Jixuan Sun
Jia Xu
Min Wu
Xiaojiao Li
Zhijie Liu
Qingfeng Dong
Yu Sun
Yanhua Ding

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1580883

161 views

Original Research

Accepted on 04 Jul 2025

THE EFFECTS OF BENRALIZUMAB ON LUNG VOLUME CHANGES DURING EXERCISE IN EXPERIMENTAL SETTING IN SEVERE ASTHMATICS: A PILOT STUDY

in Respiratory Pharmacology

Alida Benfante
Alessandra Tomasello
Lorena Gentile
Alessia Leonarda Lisotta
Paola Marasà
Salvatore Battaglia
Nicola Scichilone

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1611168

125 views

Editorial

Published on 03 Jul 2025

Editorial: Use of bioactives for treatment of respiratory diseases

in Respiratory Pharmacology

Alan de Aguiar Lopes
Akinori Nagato
Frank Bezerra
Samuel Santos Valenca
Sabina Antonela Antoniu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1630486

411 views

Case Report

Published on 02 Jul 2025

Case Report: Omalizumab combined with voriconazole for the treatment of ABPA complicating IPA: a case report

in Respiratory Pharmacology

Tingrui Zhao
Yukai Chen
He Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1588182

425 views

Review

Accepted on 30 Jun 2025

Mapping the Oxidative Landscape in Cystic Fibrosis: Methodological Frontiers and Application

in Respiratory Pharmacology

Giorgio Cozza
Michela Rubin
Ilaria Artusi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1632924

Review

Published on 26 Jun 2025

Oxidative stress in ARDS: mechanisms and therapeutic potential

in Respiratory Pharmacology

Fengyun Wang
Ruiqi Ge
Yun Cai
Mingrui Zhao
Zhen Fang
Jingguo Li
Chengzhi Xie
Mei Wang
Wanyue Li
Xiaozhi Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1603287

475 views

Original Research

Published on 25 Jun 2025

Role and mechanism of IGFBP5 in the real-ambient particulate matter exposure-induced chronic lung injury

in Respiratory Pharmacology

Ningning Chen
Yuan Qi
Wanli Ma
Xiaoxiao Zhu
Xiaoying Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1604301

318 views

Case Report

Published on 25 Jun 2025

Case Report: Polymyxin B-induced anaphylactic shock

in Respiratory Pharmacology

Weiqian Liu
Bo Gao
Shaowei Xie
Yu Yin

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1594127

333 views

Original Research

Published on 19 Jun 2025

Drug-related problems in elderly patients with AECOPD and pharmaceutical intervention practice: a prospective study

in Respiratory Pharmacology

Zengqing Ma
Hongjun Shi
Guojun Hong
Lianping Wu
Yu Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1596795

608 views

Original Research

Published on 18 Jun 2025

Oral Angiotensin-(1-7) formulation after established elastase-induced emphysema suppresses inflammation and restores lung architecture

in Respiratory Pharmacology

Giselle Santos Magalhaes
Alicia Villacampa
Maria Gloria Rodrigues-Machado
Maria Jose Campagnole-Santos
Robson Augusto Souza Santos
Carlos F. Sánchez-Ferrer
Concepción Peiró

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1540475

704 views

Original Research

Published on 13 Jun 2025

Clinical features and genetic spectrum of children with primary ciliary dyskinesia in central China: a referral center retrospective analysis

in Respiratory Pharmacology

Xiaoning Zhang
Xiuhong Jin
Zhiying Zhang
Yanqiong Wang
Xiangfeng Zhang
Zhen Dong
Haiming Yang
Yuelin Shen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1526675

722 views